Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Bronchodilator response as a hallmark of uncontrolled asthma: a randomised clinical trial.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Fernandes, Ana Luisa Godoy (AUTHOR); Amorim, Maria Marta (AUTHOR); Caetano, Lilian Ballini (AUTHOR); Dracoulakis, Samir (AUTHOR); Araruna, Alexandre Augusto Ramalho (AUTHOR); Faresin, Sonia Maria (AUTHOR); Santoro, Ilka Lopes (AUTHOR)
- Source:
Journal of Asthma. May2014, Vol. 51 Issue 4, p405-410. 6p. 1 Diagram, 2 Charts, 2 Graphs.
- Additional Information
- Subject Terms:
- Abstract:
Introduction: The goal of this study is to determine whether bronchodilator (BD) response can be used as a reliable measure of asthma control by analyzing the effects of a short course of oral corticosteroids (OC) or placebo (P) on spirometry, sputum cytology and BD response in controlled asthma patients scoring less than 1.5 on the ACQ5. Methods: Seventy patients with moderate to severe asthma who were undergoing combination therapy and were considered to be controlled based on ACQ5 scores, but who exhibited persistent positive BD response, were randomly assigned to two groups, one receiving OC and the other P. Patients were evaluated before and after 2 weeks of treatment. Intervention response (comparison of FEV1 before and after OC or P treatment) was used as a measure of intervention efficacy, with values equal to or greater than 200 mL considered positive. Results: Patients who received OC showed significant improvement in FEV1, and no longer exhibited a positive BD response. Those in the P group showed no change. In addition, sputum eosinophil counts significantly decreased in the OC group. Conclusions: BD response can be used as a reliable measure of asthma control. This study suggests that ACQ5 scores alone are not sufficient to fully assess asthma control, and that BD response should be included as an essential measurement in any algorithm of asthma control evaluation. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of Journal of Asthma is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.